Contact

Contact Edriza

Ask for a walkthrough or an answer to a pharmacovigilance question. We reply within 24–48 hours.

Contact form

Send us a message

Fields marked * are required. We use your details only to answer you; see our privacy policy.

Email: info@edriza.com

Covered regions: India, EU, USA, UK, Canada, Japan, Middle East, Asia, Australia

Response time: 24–48 hours

We reply within 24–48 hours. Your details are used only to answer you (see our privacy policy).

Talk to us about your pharmacovigilance

Tell us about your products, the sources you monitor and your monthly case volume. We will answer and, if you wish, give you a walkthrough of the Edriza platform. Edriza takes cases from literature, local journals, your mail box, intake ICSRs and uploaded documents to a XSD-checked E2B(R3) XML and submission, with aggregate reports and signal detection in the same platform.

What happens after you write

  1. Your message is stored with Edriza and sent to our team at info@edriza.com.
  2. We reply within 24–48 hours, usually with a few questions about your volumes, sources and markets.
  3. If you wish, we show you the platform on your own sources and agree the modules you need.

Edriza is one platform: no separate tools or extra subscriptions for literature screening, case processing, QC, E2B generation, submissions, aggregate reports and signal detection. Two independent AI agents plus a QC agent on every case; your experts stay in control.

What to include in your message

A short description is enough to start. These details help us answer precisely:

  • The number of products, and the countries where they are authorised.
  • Your monthly volumes: literature articles screened, ICSRs processed, mails received in the safety mailbox.
  • The aggregate reports you prepare each year (PSUR, PBRER, PADER, DSUR).
  • Which modules you are interested in: Live Scan, Local Journal, RA Monitoring, Mail Box, Intake, Document Scan, aggregate reports, signal detection, submissions.
  • How your PV work is done today: an in-house team, a service provider, or both.

Where we work

We support companies in India, the European Union, the United States, the United Kingdom, Canada, Japan, the Middle East, Asia and Australia, under the ICH guidelines and the regional rules of each authority, with regulatory authority support for more than 114 countries.

Our office

Pro Edriza Technologies Pvt. Ltd., First Floor, Enkay Tower, Plot No. B & B1, Vanijya Nikunj, Udyog Vihar, Phase V, Gurgaon, Haryana 122016, India. E-mail: info@edriza.com.

End-to-end pharmacovigilance on a single platform

No separate tools or extra subscriptions for literature screening, case processing, QC, E2B generation, submissions, aggregate reports and signal detection.